Altace and Remodulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Altace (ramipril) and Remodulin (treprostinil sodium). Common drug interactions include abdominal pain among females and blood pressure systolic increased among males.

The phase IV clinical study analyzes what interactions people have when they take Altace and Remodulin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Remodulin?

Remodulin has active ingredients of treprostinil sodium. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,843 Remodulin users. Check the latest studies of Remodulin.



On Jul, 13, 2026

11 people who take Altace and Remodulin together, and have interactions are studied.

Altace and Remodulin drug interactions.

What are the common drug interactions of Altace and Remodulin, by gender? *:

female:

  1. Abdominal pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Sinus disorder (disease of sinus)
  7. Vomiting
  8. Blood bilirubin increased
  9. Death
  10. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

male:

  1. Blood pressure systolic increased
  2. Body temperature decreased
  3. Medical device complication
  4. Pain in extremity
  5. Vomiting
  6. Diarrhoea
  7. Erythema (redness of the skin)
  8. Flushing (the warm, red condition of human skin)
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Headache (pain in head)

What are the common drug interactions of Altace and Remodulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Disease progression
  4. Obesity (having too much body fat)
  5. Pancreatitis (inflammation of pancreas)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Type 2 diabetes mellitus

50-59:

  1. Infusion site pain
  2. Injection site haemorrhage (bleeding from injection site)
  3. Medical device complication
  4. Pain in extremity
  5. Vomiting
  6. Blood pressure systolic increased
  7. Body temperature decreased
  8. Diarrhoea
  9. Erythema (redness of the skin)
  10. Flushing (the warm, red condition of human skin)

60+:

  1. Blood bilirubin increased
  2. Fluid overload (too much fluid in the blood)

What are the existing conditions these people have? *

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 27.27%
  2. Stress And Anxiety: 1 person, 9.09%
  3. Insomnia (sleeplessness): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and Remodulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Altace and Remodulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remodulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Altace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remodulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ramipril and treprostinil sodium (the active ingredients of Altace and Remodulin, respectively), and Altace and Remodulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: